Back to results
Not yet recruitingPhase 2

dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

NCT06072326

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Steno Diabetes Center Aarhus

Aarhus, Denmark

+6 additional locations

Contact

Hiddo J Lambers Heerspink, Phd, PharmD

+31-50-3617859h.j.lambers.heerspink@umcg.nl
View on ClinicalTrials.gov
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation — TrialFind